Variant report
Variant | esv3512301 |
---|---|
Chromosome Location | chr4:3827716-3827884 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:10)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:10 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:3824171..3826051-chr4:3826222..3829148,2 | K562 | blood: | |
2 | chr4:3811417..3813091-chr4:3826463..3828582,2 | MCF-7 | breast: | |
3 | chr4:3483725..3485778-chr4:3827881..3829780,2 | MCF-7 | breast: | |
4 | chr4:3821388..3825394-chr4:3826472..3830558,5 | MCF-7 | breast: | |
5 | chr4:3822546..3824664-chr4:3827698..3829669,2 | K562 | blood: | |
6 | chr4:3827867..3829717-chr4:3860178..3862948,2 | MCF-7 | breast: | |
7 | chr4:3784486..3786605-chr4:3826007..3828204,2 | MCF-7 | breast: | |
8 | chr4:3825945..3828484-chr4:3829762..3832273,2 | K562 | blood: | |
9 | chr4:3826762..3828884-chr4:3861993..3864451,2 | MCF-7 | breast: | |
10 | chr4:3827600..3830833-chr4:3837890..3839545,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112331645 | chr4:3827719-3827720 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs371466863 | chr4:3827724-3827725 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375011713 | chr4:3827733-3827734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376613637 | chr4:3827736-3827737 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs200677075 | chr4:3827737-3827738 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs111760039 | chr4:3827748-3827749 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542915543 | chr4:3827749-3827750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553294732 | chr4:3827759-3827760 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555866868 | chr4:3827760-3827761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573099311 | chr4:3827761-3827762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538754135 | chr4:3827762-3827763 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545300936 | chr4:3827763-3827764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565364634 | chr4:3827766-3827767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530927002 | chr4:3827769-3827770 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544568650 | chr4:3827771-3827772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs80050584 | chr4:3827774-3827775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529163350 | chr4:3827775-3827776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs28535641 | chr4:3827783-3827784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs62291148 | chr4:3827785-3827786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116051630 | chr4:3827787-3827788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs28629943 | chr4:3827789-3827790 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144426820 | chr4:3827792-3827793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs188400025 | chr4:3827800-3827801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145808412 | chr4:3827802-3827803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs138454882 | chr4:3827806-3827807 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536768536 | chr4:3827809-3827810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs193037086 | chr4:3827811-3827812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375755112 | chr4:3827813-3827814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182791288 | chr4:3827815-3827816 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs187076851 | chr4:3827816-3827817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369316856 | chr4:3827818-3827819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs28514927 | chr4:3827826-3827827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs539192260 | chr4:3827836-3827837 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183746052 | chr4:3827843-3827844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188121429 | chr4:3827847-3827848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs193100564 | chr4:3827852-3827853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs185571544 | chr4:3827853-3827854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs190053445 | chr4:3827857-3827858 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181773229 | chr4:3827860-3827861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs561406908 | chr4:3827861-3827862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574881519 | chr4:3827864-3827865 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540657203 | chr4:3827868-3827869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184099793 | chr4:3827869-3827870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188539000 | chr4:3827873-3827874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181007150 | chr4:3827878-3827879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112214679 | chr4:3827883-3827884 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Retinitis pigmentosa | 18421352 | CNVD |
Wolf-Hirschhorn syndrome | 19259404 | CNVD |
Bladder cancer | 19242612 | CNVD |
Breast cancer | 19242612 | CNVD |
Congenital anomalies of the kidney and urinary tract | 19242612 | CNVD |
abnormal development | 18461090 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 21544195 | CNVD |
Melanoma | 20688739 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21509527 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Lung cancer | 18438408 | CNVD |
Ependymoma | 20639864 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:3821400-3828400 | Enhancers | HepG2 | liver |
2 | chr4:3821600-3829400 | Weak transcription | A549 | lung |
3 | chr4:3823800-3832400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
4 | chr4:3824000-3828600 | Weak transcription | Brain Germinal Matrix | brain |
5 | chr4:3824200-3828600 | Weak transcription | Spleen | Spleen |
6 | chr4:3824400-3828600 | Weak transcription | Pancreas | Pancrea |
7 | chr4:3824400-3831200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr4:3825800-3828600 | Weak transcription | Ovary | ovary |
9 | chr4:3827000-3828600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr4:3827200-3831400 | Enhancers | Liver | Liver |